Ligand · FF7
FF7 · 5'-O-[(R)-{[(R)-[(R)-chloro(phosphono)methyl](hydroxy) phosphoryl]oxy}(hydroxy)phosphoryl]-2'-deoxycytidine
FF7, 5'-O-[(R)-{[(R)-[(R)-chloro(phosphono)methyl](hydroxy) phosphoryl]oxy}(hydroxy)phosphoryl]-2'-deoxycytidine (C10 H17 Cl N3 O12 P3, 499.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding…
- Component
- FF7
- Formula
- C10 H17 Cl N3 O12 P3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
FF7 in 2 structures; the first of them:
- 6CTT · Ternary complex crystal structure of DNA polymerase Beta with a dideoxy terminated primer… · FF7 A401 · binds DG6, 2DA10, GLY179, SER180, ARG183, SER188, GLY189, ASP190 and 8 more
- 6CTT · Ternary complex crystal structure of DNA polymerase beta with a dideoxy terminated primer… · FF7 A401 · binds DG6, 2DA10, GLY179, SER180, ARG183, SER188, GLY189, ASP190 and 8 more
Residues it binds most
ASP 2, GLY 2, SER 2, 2DA 2, ARG 2, ASN 2, DG 2, PHE 2, THR 2, TYR 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.